[A case of inflammatory breast cancer successfully treated with 5'-DFUR and MPA].

Abstract

A 67-year-old female with extensive inflammatory breast cancer was treated with oral chemoendocrine therapy using 5'-deoxy-5-fluorouridine (5'-DFUR) 1,200 mg and medroxyprogesterone acetate (MPA) 1,200 mg before intra-arterial infusion chemotherapy, which made the extensive inflammatory skin lesion improve remarkably. Sequential intra-arterial infusion made the skin lesion completely disappear. But the main tumor remained, so extended mastectomy was performed. These findings suggested that this therapy was effective for the prevention of extension of the skin lesion on the inflammatory breast cancer, and also served as induction therapy for this modality.

• Authors: M Kusama, Y Koyanagi, M Sekine, H Serizawa, Y Ebihara, T Hirota, Y Nakamura, T Matsunaga
• Journal: Gan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 21 Issue 12 Pg. 2049-52 (Sep 1994) ISSN: 0385-0684 [Print] Japan
• PMID: 8085857 (Publication Type: Case Reports, English Abstract, Journal Article)

Chemical References

• Antineoplastic Agents
• Floxuridine
• Medroxyprogesterone Acetate
• doxifluridine

Topics

• Administration, Oral
• Aged
• Antineoplastic Agents (administration & dosage)
• Breast Neoplasms (drug therapy, surgery)
• Female
• Floxuridine (administration & dosage)
• Humans
• Mastectomy, Extended Radical
• Mastitis (drug therapy, surgery)
• Medroxyprogesterone Acetate (administration & dosage)